In cultured midbrain organoids from PD patients with the LRRK2-G2019S mutation, high-content imaging data has shown decreased dopaminergic differentiation, altered mitochondrial morphology, and increased cell death compared to the organoids from isogenic lines [102]. This evidence concerns the gene LRRK2 and Parkinson disease.